Skip to main content

Advertisement

Log in

Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Recent studies have suggested that Crk-like adapter protein (CrkL) and epithelial-to-mesenchymal transition (EMT) induced by CCL19/CCR7 play an important role in ovarian epithelial carcinogenesis. However, the regulatory mechanisms of CrkL on the CCL19/CCR7 signaling pathways in epithelial ovarian carcinomas (EOC) are not well characterized. Here, CCR7 and CrkL proteins were tested in 30 EOC tissues and cell lines. In vitro, the roles of CrkL in CCL19-stimulated SKOV-3 cell invasion and migration were investigated. In this work, CCR7 and CrkL over-expressed in EOC tissues and cell lines and correlated with FIGO stage and lymph node metastasis. Moreover, CCR7 and CrkL serve as an independent prognostic factor. In SKOV-3 cells, CrkL knockdown markedly suppressed the CCL19-stimulated expression of p-ERK and EMT biomarkers (N-cadherin, Snail and MMP9), compared with control. In contrast, p-AKT expression level did not change. On the other hand, functional analysis revealed CrkL knockdown could significantly decrease SKOV-3 cell invasion number of transwell invasion assay, and wound closure area of wound healing assay, compared to control. In conclusion, CrkL regulates CCL19/CCR7-induced EMT via ERK signaling pathway in EOC patients, which further suggested CrkL could be suggested as an efficient target in ovarian cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053–64.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Coleman RL, Monk BJ, Sood AK, et al. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10:211–24.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–8.

    Article  PubMed  Google Scholar 

  4. Gurung A, Hung T, Morin J, et al. Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates. Histopathology. 2013;62:59–70.

    Article  PubMed  Google Scholar 

  5. Sriram G, Birge RB. Emerging roles for crk in human cancer. Genes Cancer. 2010;1:1132–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Guo C, Liu S, Sun MZ. The role of CT10 regulation of kinase-like in cancer. Future Oncol. 2014;10:2687–97.

    Article  CAS  PubMed  Google Scholar 

  7. Kumar S, Fajardo JE, Birge RB, et al. Crk at the quarter century mark: perspectives in signaling and cancer. J Cell Biochem. 2014;115:819–25.

    Article  CAS  PubMed  Google Scholar 

  8. Han B, Luan L, Xu Z, et al. Clinical significance and biological roles of CRKL in human bladder carcinoma. Tumour Biol. 2014;35:4101–6.

    Article  CAS  PubMed  Google Scholar 

  9. Evren S, Ma XZ, Sakac D, et al. SHP-1 protein tyrosine phosphatase associates with the adaptor protein CrkL. Exp Hematol. 2012;40:1055–9.

    Article  CAS  PubMed  Google Scholar 

  10. Birge RB, Kalodimos C, Inagaki F, et al. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal. 2009;7:13.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Joseph JV, Balasubramaniyan V, Walenkamp A, et al. TGF-β as a therapeutic target in high grade gliomas promises and challenges. Biochem Pharmacol. 2013;85:478–85.

    Article  CAS  PubMed  Google Scholar 

  12. Wick W, Naumann U, Weller M. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des. 2006;12:341–9.

    Article  CAS  PubMed  Google Scholar 

  13. Murphy PM. Chemokines and the molecular basis of cancer metastasis. New Engl J Med. 2001;345:833–5.

    Article  CAS  PubMed  Google Scholar 

  14. Moschovakis GL, Förster R. Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease. Eur J Immunol. 2012;42:1949–55.

    Article  CAS  PubMed  Google Scholar 

  15. Müller G, Lipp M. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation. 2003;10:325–34.

    Article  PubMed  Google Scholar 

  16. Matsuda M, Ota S, Tanimura R, et al. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins. J Biol Chem. 1996;271:14468–72.

    Article  CAS  PubMed  Google Scholar 

  17. Ding Y, ShimadaY Maeda M, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003;9:3402–12.

    Google Scholar 

  18. Liu FY, Safdar J, Li ZN, et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. Int J Oncol. 2014;45:2502–10.

    CAS  PubMed  Google Scholar 

  19. Suda K, Mizuuchi H, Murakami I, et al. CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation. Lung Cancer. 2014;85:147–51.

    Article  PubMed  Google Scholar 

  20. Cheng S, Han L, Guo J, et al. The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas. Tumour Biol. 2014;35:12293–8.

    Article  CAS  PubMed  Google Scholar 

  21. Nizard P, Ezan F, Bonnier D, et al. Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells. BMC Genomics. 2014;15:1169.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Copple BL. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms. Liver Int. 2010;30:669–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol. 2010;21:89–92.

    Article  Google Scholar 

  24. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.

    Article  CAS  PubMed  Google Scholar 

  25. Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007;117:3810–20.

    PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We greatly thank other members of Sandy Lab for valuable suggestions and writing.

Conflict of interest

The authors indicated no potential conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shaomei Cheng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, S., Guo, J., Yang, Q. et al. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas. Med Oncol 32, 47 (2015). https://doi.org/10.1007/s12032-015-0494-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-015-0494-1

Keywords

Navigation